OBJECTIVES: Since the introduction of video-assisted lobectomy for non-small-cell lung cancer (NSCLC) into clinical practice, it has been discussed controversially whether mediastinal lymphadenectomy can be performed as effectively as an open procedure via thoracotomy. Therefore, we address this issue in a prospective randomized trial conducted in our institution.
INTRODUCTION
According to the European Society of Thoracic Surgeons (ESTS) guidelines for intraoperative lymph node staging in nonsmall-cell lung cancer (NSCLC), a systematic lymph node dissection is recommended in all cases. One exception can be made for peripherally located T1 squamous cell tumours with negative hilar and interlobar nodes on frozen section, in which case a lobe-specific systematic nodal dissection is acceptable. This recommendation applies regardless of the operative method (open thoracotomy or minimally invasive) [1] .
Since 1994, as the first anatomical video-assisted thoracoscopic (VATS) lobectomy was reported [2] , a large number of publications has emerged on the feasibility as well as the postoperative and oncological outcome of this procedure, particularly in patients with early stage NSCLC. Recently, analysis of the prospective database of the Society of Thoracic Surgeons (9033 pulmonary resections for lung cancer operated on between 1999 and 2006) revealed that about 20% of the lobectomies were performed as a VATS procedure with an increasing number ranging from 21.6% in 2004 to 32% in 2006 [3] . In few dedicated 'VATS centres', over 80% of the lung resections are done minimally invasive [4] .
Despite the growing acceptance of the method, concerns about compromised long-term oncological outcome and adequate intraoperative lymph node staging persist. Here, it is speculated that a systematic lymph node dissection can be less completely accomplished by means of VATS than with open thoracotomy.
In this paper, we present a prospective, randomized trial comparing the completeness of the hilar and mediastinal lymphadenectomy in patients with clinical Stage I NSCLC treated either by VATS lobectomy or by open lobectomy via an anterolateral approach.
MATERIALS AND METHODS

Study design and patients characteristics
In our institution, we conducted a prospective, randomized trial to assess the outcome of lobar resection for clinical Stage I NSCLC treated either by VATS lobectomy or by the conventional procedure between May 2008 and December 2011. The study was primarily designed to evaluate the quality of life after these operations; a large number of other clinical and resource-related parameters were assessed and evaluated, including lymphadenectomy.
The study was approved by the ethics committee of our institution, and for each patient, an informed consent was obtained before inclusion into the study.
Sixty-six patients who met the inclusion criteria (Table 1) were randomized either to the VATS (Group A) or to the open lobectomy (Group B) arm (Fig. 1) . From 34 patients in Group A, 2 (5.9%) were excluded due to conversion to thoracotomy. Both patients had a left-sided tumour. The patient characteristics of the two resulting, equally large groups (each 32 patients) are shown in Table 2 . In Group A, 21 patients had a right-sided tumour and 11, a left-sided tumour (65.6 and 34.4%, respectively), and in Group B, 17 had a right-sided and 15, a left-sided tumour (53 and 47%, respectively).
Lymph nodes were classified according to the map proposed in 2009 by the International Association for the Study of Lung Cancer (IASLC) [5] . For statistical analysis, the lymph node stations were grouped into nodal zones, similar to the grouping method proposed by the IASLC [6] . As Figure 2 shows, the following zones resulted: Zone 1 (level 2R and 4R), Zone 2 (level 7), Zone 3 (level 8R and 9R), Zone 4 (level 10R, 11R and 12R), Zone 5 (level 4L), Zone 6 (level 5 and 6), Zone 7 (level 8L and 9L) and Zone 8 (level 10L, 11L and 12L). The main reason for this grouping method was that the lymph nodes in one nodal zone are dissected and pathologically analysed together. The major difference to the grouping method used by IASLC was that the N1 levels were not divided into peripheral (level [12] [13] [14] and hilar (level 10 and 11) [6] .
Histological examination was done in all cases in our institution, and in accordance with the recommendations for processing and reporting of lymph node specimens submitted for the evaluation of metastatic disease proposed by the Association of Directors of Anatomic and Surgical Pathology [7] .
For each side and procedure, the number of removed lymph nodes per zone was counted and the mean was calculated and then proved to be of statistical significance. For the subcarinal lymph nodes, which can be dissected from both sides, an additional analysis was performed to evaluate whether there is a difference between the right-and left-sided resections (Table 3) .
Relevant parameters describing the patient characteristics (Table 2 ) and perioperative outcomes (Table 4) were also evaluated.
For normally distributed continuous variables (e.g. lymph nodes (LN)/patient and LN/compartment), the mean and standard deviation were calculated, the median for the data with outliers. The statistical significance was evaluated using a t-test for the mean and a Mann-Whitney U-test for the median. For the nominal data, a χ 2 test was used. The difference was considered significant for a P-value <0.05. The statistical workout was performed using SPSS Version 19.0 (SPSS, Chicago, IL, USA).
Operation technique
In our institution, video-assisted lobectomy is usually performed with three incisions and an anterior approach [the operating surgeon stays in front of the patient]. The utility incision is placed just anterior to the border of the latissimus dorsi muscle After exploration of the entire pleural cavity on the affected side with the exclusion of other lesions and clearly determined tumour localization (correspondency to the lobe to be resected), the first step of every lobar resection is to transect the ligamentum pulmonale and dissect the lymph nodes level 9 and 8. At this point, the inferior lung vein should be visualized to exclude an anatomical variant, which could lead to an accidental closure of both veins, particularly on the left side. The circumferential exposure of the entire lung hilum and the preparation of the lobar structures with consecutive closure and section (from anterior to posterior) follow. The lymph nodes level 10 and the levels 11 and 12 of the affected lobe are dissected and removed, separately or together with the resected lung. After transection of the fissure and removal of the lobe, the mediastinal lymph node dissection is completed. All patients, regardless of tumour size and location, underwent a systematic nodal dissection, which included for the right side, the levels 2R, 4R, 7, 8, 9, 10 and 11 and 12 of the affected lobe, and for the left side, the levels 5, 6, 7, 8, 9, 10 and 11 and 12 of the involved lobe. The lymph nodes were dissected as a compartment, with care taken to preserve the integrity of the resected structure and to remove all the surrounding fatty tissue. A compartment was considered completely dissected when the anatomical landmarks (e.g. for level 7, the corresponding portions of both mainstem bronchi, oesophagus and pericardium as shown in Fig. 3.) were clearly recognizable and without nodal structures.
RESULTS
The investigations used preoperatively for mediastinal staging were positron emission tomography-computed tomography (PET-CT; 71.9 in Group A and 65.6% in Group B) or CT (28.1 in Group A and 34.4% in Group B). In the case of suspicion of lymph node metastasis, an additional invasive investigation was performed (in both groups together endobronchial ultrasound (EBUS) in 3 cases, mediastinoscopy in 7 and EBUS plus mediastinoscopy in 3).
The mean number of the overall removed lymph nodes (intrapulmonal, hilar and mediastinal) was, for the VATS group, 24 ± 7.5 for the right side and 25.1 ± 9.3 for the left side, and for the open lobectomy group, 25.2 ± 7.2 for the right side and 21.1 ± 10.4 for the left side, without a statistically significant difference between both groups (P = 0.98 for the right side and P = 0.32 for the left side). The same was true analysing only the mediastinal lymph node zones (right side 17.5 ± 6.7 for Group A and 18.4 ± 6.7 for Group B with P = 0.58 and for the left side, 14.6 ± 9.5 for Group A and 12 ± 5.4 for Group B with P = 0.39). These data are shown in Fig. 4 . Furthermore, the difference between the two procedures regarding the number of removed lymph nodes for each zone, as described above, was analysed. Table 3 shows the data that emerged, which are comparable for both groups without a statistically significant difference.
The mean operative time for the VATS lobectomy was 187 min and for the open approach, half hour less (158 min), which was statistically highly significant (P = 0.003). Because the operative time is clearly defined, as the time from incision to skin closure and the lymph node dissection is an integral part of the operation, we did not assess the time needed for the lymphadenectomy separately.
The type of operation had no impact on the duration of chest drainage (4 days for both groups), and the length of hospital stay was 2 days longer for the open thoracotomy group (11 vs 9 days) without reaching statistical significance.
Analysing the early postoperative outcome with respect to morbidity (Table 4) , there was a significant trend favouring the VATS lobectomy. So, with 19 patients (59.4%) in Group B, a total of 34 complications were registered, which was significantly more (P = 0.039) than in Group A (8 patients and 11 complications). Among these, pneumonia and acute or chronic respiratory failure reached statistical significance. The only complication that was more frequent in the VATS group was a postoperative pneumothorax after chest tube removal (12.5 vs 0%, P = 0.039). In all cases, this complication was treated by the insertion of chest drainage, and in 1 case, a blood pleurodesis was necessary to obliterate the persisting air leakage.
Complications, such as chylothorax and pleural effusion, which might be associated with the node dissection, were similar in both groups. Bleeding and laryngeal nerve damage did not occur in any patient of the entire study population.
The only reoperations were observed in the open thoracotomy group in 2 patients with postoperative empyema (without bronchus stump insufficiency), but did not reach statistical significance.
In the entire study cohort, a single case of operative mortality was observed in the VATS group. The patient who had an idiopathic lung fibrosis associated with the lung tumour experienced a dramatic progress of the underlying disease without pneumonia several days after the resection and died of lung failure 32 days postoperatively.
Regarding stage migration, because in our study all patients included were clinical Stage I, there is only the possibility of pathological upstaging. A total of 7 unexpected N1 (10.9%) and 3 N2 (4.7%) were encountered in the entire cohort (VATS and open group). Therefore, a total of 10 patients (15.6% of both groups) resulted with the need for adjuvant treatment due to postoperative upstaging. Of these patients, 7 had a negative PET-CT preoperatively, 3 a CT with normal-sized lymph nodes and none, an EBUS or mediastinoscopy. There were 6 patients with adenocarcinoma, 3 with squamous cell tumour and 1, large cell carcinoma.
DISCUSSION
Systematic nodal dissection is the most precise method of lymph node staging and is therefore recommended by the ESTS for all resections in NSCLC patients. One exception can be made for peripherally located T1 squamous cell tumours. In this situation, a lobe-specific systematic nodal dissection is acceptable, if there are at least three negative hilar and interlobar lymph nodes on frozen section and three more mediastinal lymph node stations including the subcarinal region are removed [1] .
Even if an oncological benefit for the systematic nodal dissection could not be proven until now, an accurate mediastinal staging results in a differentiated therapy, often with the addition of chemotherapy, and therefore has an important prognostic impact [8] . The comparison of systematic nodal dissection with lymph node sampling analysed in the ACOSOG Z0030 Study showed the staging superiority of the systematic nodal dissection. In this prospective study, 1111 patients with clinical Stage I NSCLC were included (524 patients received a complete mediastinal lymph node dissection after the systematic sampling with frozen section and negative result). In 4% of the patients, an occult N2 was found despite systematic nodal sampling. In terms of survival, there was no statistical difference between the systematic sampling and the nodal dissection group [9] .
Using non-invasive mediastinal staging methods such as PET-CT, the incidence of nodal upstaging is much higher. In a recently published retrospective analysis that included 96 patients with early stage NSCLC (T1-2, N0-1 and M0) preoperatively staged with PET-CT, the rate of unexpected N2 was found to be 10.5 with 4.2% of the PET-negative patients having multilevel N2 disease. In these series, all upstagings were in patients with adenocarcinoma and involved mostly the stations 7, 4R and 2R. In this study, a dissection of the level 4L was performed in all 31 patients (33%) with left-sided tumour. Interestingly, only in 1 case, an unexpected N2 on the left side could be found, which was due to the levels 9 and 7 [10] .
The actual number of the overall dissected lymph nodes, as well as those removed in each station, is highly variable. In our experience, an average of 21-25 lymph nodes were resected, 12-18 of them from mediastinal lymph node levels. Similar numbers have been published by other European and Northern American studies on lymphadenectomy. For example, in the ACOSOG Z0030 Study, the median number of additionally resected nodes after the systematic sampling was 18 for both sides (range 1-72 for right-sided and 4-69 for left-sided tumours) [9] . In a secondary analysis of this randomized clinical trial, the median total number of lymph nodes harvested was similar between video-assisted thoracoscopy and open resection: 15 nodes (range 5-48) for the VATS and 19 nodes (range 2-83) for the thoracotomy group [11] .
In contrast, in Japanese publications, the number of dissected lymph nodes is significantly higher. The results of a trial published in 2002 by Sagawa demonstrated that, using VATS, a complete nodal dissection can be feasible. In 29 patients, an open thoracotomy was performed after completion of the VATS lymphadenectomy, to eventually resect the remnants of lymphatic tissue. For both sides, an average of 1.2 lymph nodes and 0.2 g tissue could be supplementarily removed, representing only 2-3% of the entire tissue to be harvested. The mean number of lymph nodes removed by VATS was 40.3 for the right side and 37.1 for the left side [12] .
Complications such as chylothorax, pleural effusion, bleeding and nerve damage can eventually occur following lymph node dissection. In our study, these events were similar in both groups. However, there were more complications in the thoracotomy group, but without reaching statistical significance (Table 4) . Altogether, the patients in the VATS group had significantly less morbidity due to a reduced incidence of pneumonia and chronic respiratory failure. The only complication that was encountered significantly more frequently in the VATS group was a postoperative pneumothorax (lung collapse after successful removal of the chest tube). A clear explanation for this complication cannot be given because all patients were treated conservatively, and none was reoperated. Outside the current study, we reoperated a few patients after a VATS lobectomy for a persisting air leakage, and we found a parenchyma necrosis at the mechanical resection line. Therefore, this might be an explanation for the renewed lung collapse after VATS lobectomy and initially successful removal of the chest tube.
From the technical point of view, we favour a harmonic scalpel (as a clamp) for the lymph node dissection. This technique has, in our opinion, two advantages: first, it simultaneously seals and cuts the tissue and, therefore, there is no need to change instruments between manoeuvres, and secondly, it has a very low risk of damaging the surrounding structures because the energy is delivered only between the two branches of the grasping clamp.
The difficulties that can be encountered with the VATS lymphadenectomy are mostly due to the difficult exposure of some anatomical regions to be dissected. The subcarinal group, in particular, poses the problem of a sufficient retraction of the lung and a clear exposure of the depth in order to dissect along the contralateral mainstem bronchus. On the other hand, the visualization of the anatomical structures with the optic system is excellent.
A limitation of our study is the lack of dissection of station 4L. This is similar to other published series such as the ACOSOG Z0030 Trial, in which the investigators did not include the removal of these lymph nodes as mandatory in the study protocol [9, 13] . For a complete removal of this station, the transection of the ligamentum Botalli is mostly necessary. The published series that refer to the dissection of station 4L are small, so that pertinent interpretations on morbidity and oncological aspects, such as the incidence of unexpected lymph node metastasis in this position cannot be derived [10, 14] . For clinical Stage I NSCLC, the lymphadenectomy we are performing in the aortic region clears all tissue adjacent to the aorta that lies between the upper border of the aortic arch and the left mainstem bronchus and the upper rim of the left main pulmonary artery, but we do not section the ligamentum arteriosum and dissect behind the aortic arch. The main reason therefore is the risk of producing a laryngeal nerve injury, which in our opinion stays in imbalance with the very low probability of discovering an overlooked lymph node metastasis in this location [15] .
In conclusion, this is one of the few prospective randomized trials that show that hilar and mediastinal lymphadenectomy by VATS is as effective as the open approach via an anterolateral thoracotomy. Oncological concerns with respect to intraoperative lymph node staging are no longer justified.
